Latest Conference Articles

Watch Dr. Benjamin T. Diamond, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of sustained MRD negativity during the CURE® Educated Patient® Multiple Myeloma Summit.

Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.

Watch Dr. C. Ola Landgren and Dr. David Coffey answer questions about novel treatments and the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

An expert recommends that cancer survivors and patients take several actionable steps to improve their quality of sleep.

Watch Dr. Hossein Borghaei, Dr. Jessica R. Bauman and Dr. Devika Das answer questions about supportive care during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.

Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Jared Weiss, from UNC School of Medicine, discuss neoadjuvant versus adjuvant therapy during the CURE Educated Patient Lung Cancer Summit.

CURE®’s Lung Cancer Heroes® Award Program honors and gives thanks to those heroes who have positively affected the lives of patients with lung cancer.

Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.

None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study results.

Treatment with Libtayo may improve survival over a 30-month period with no new side effects in patients with recurrent or metastatic cervical cancer, opening the doors for an immunotherapy option for these patients.

Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.